Phoslock Environmental Technologies Ltd (ASX: PET) Share Price and News

Mr Bart was appointed the Managing Director of Textile Industries Australia in 1985. The Group employed over 1,200 people and distributed product to countries worldwide. The Company manufactured and distributed the majority of bed linen in Australia under brands like Sheridan and ACTIL. The Company was sold in 1987. In 1989, Mr Bart established and chairs a number of private companies under the umbrella of the Bart Group which covered hotels, retail, commercial and residential land development and technologies which still continue to operate. The Group today employs in excess of 1,000 people and is active in local and overseas markets. In 2013, Mr Bart became Director and majority shareholder of Immunovative Therapies Limited, a private Israeli company involved in the manufacture of vaccines for the treatment of certain forms of cancer. The Company has undertaken trials in both collateral and liver cancers. He held directorship with Weebit Nano Limited (resigned 27 June 2023). He is member of Risk Committee.

Mr Boheemen's experience in commercial finance leadership spans 30 years across sectors, including healthcare, manufacturing, biotech and financial services. His experience includes Australian ASX and ASIC reporting, SEC reporting in the USA, compliance and regulatory affairs, internal and external audit work, taxation, business and financial analytics, IP protection, as well as regulatory and financial reporting locally and in the United States. He has held financial positions in both Australian and multinational organisations, including Covance, Unomedical, M.D. Sass, and New York Life Insurance. He is currently CFO of Noxopharm Limited (ASX: NOX) and CFO/Company Secretary of Audio Pixels Holdings Limited (ASX: AKP). He is chairman of Risk Committee.

Mr Newing was a securities analyst within the stockbroking industry for some decades before his retirement. He was mining analyst for most of the 1980s, at JM Bowyer and Co and then at County Natwest Securities Australia where he became a director. He is member of the Risk Committee.